Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anus Neoplasms × Probiotics × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 4 Stomach Neoplasms 3 Neoplasms 2 Mucositis 2 Malnutrition 2 Lung Neoplasms 2 Diarrhea 2 Chalazion 2 Carcinoma, Hepatocellular 2 Thyroid Neoplasms 1 Squamous Intraepithelial Lesions 1 Smoldering Multiple Myeloma 1 Psychological Well-Being 1 Polycystic Ovary Syndrome 1 Periampullary Carcinoma Nos 1 Pelvic Neoplasms 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasms, Second Primary 1 Muscle Invasive Bladder Cancer (MIBC) 1 Multiple Myeloma 1 Motor Activity 1 Monoclonal Gammopathy of Undetermined Significance 1 Liver Cirrhosis 1 Limited Stage Small Cell Lung Cancer 1 Laryngeal Neoplasms 1 Infections 1 Helicobacter Infections 1 Generalized Anxiety Disorder 1

Interventions

Fluorouracil 13 Mitomycin 9 Radiotherapy 8 Capecitabine 8 Radiation 7 pembrolizumab 5 Surveys and Questionnaires 5 Drug Therapy 5 Cisplatin 5 Paclitaxel 4 Magnetic Resonance Spectroscopy 3 Irinotecan 3 Carboplatin 3 Biopsy 3 atezolizumab 2 Oxaliplatin 2 Observation 2 Nivolumab 2 Immune Checkpoint Inhibitors 2 Cyclophosphamide 2 Cetuximab 2 Blood Specimen Collection 2 toripalimab 1 tislelizumab 1 regorafenib 1 nanocis 1 durvalumab 1 dehydroftorafur 1 cemiplimab 1 avelumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03870607 2023-01-17

BISQUIT

AC Camargo Cancer Center

Phase 2 Unknown

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡